Drug
HS 20136 2
HS 20136 2: highest development phase Phase 1, developed by Hansoh Pharmaceutical. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| HS-20136-2 injection NCT07483437 | Phase 1 | Healthy |
| HS-20136-2 NCT07716241 | Phase 1 | Obesity |
Latest
No recent events.
Follow HS 20136 2 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.